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Sleep Apnea (SA) is gaining increased attention among military populations due 
to the increasing prevalence rates (40-60%) and risk of serious health complications (i.e., 
cognitive decline, stroke) when untreated. Unfortunately, adherence to Continuous 
Positive Airway Pressure (CPAP; the gold standard treatment) is chronically low. This 
study examined the efficacy of a 6-week CBT group intervention to increase CPAP 
adherence among veterans diagnosed with SA and prescribed CPAP treatment. A final 
sample of 35 veterans was randomly assigned either to treatment as usual (TAU) or TAU 
plus the CBT group intervention. Participants completed various self-report measures and 
a therapist-administered cognitive screening at baseline and a 3-month post-assessment. 
On average the sample had severe SA, were obese, reported poor sleep quality, exhibited 
significant daytime sleepiness, and reported clinically significant symptoms of PTSD 
(59%), depression (62%), and anxiety (66%). Unfortunately, due to inconsistent and 
invalid CPAP adherence reporting in participant’s medical charts, we were unable to 
analyze this information. Veterans in the CPAP group condition reported a reduction in 
their mental health symptoms at the post-assessment, with small to moderate effect sizes 
(d = .20 to .50) compared to an increase in PTSD and anxiety symptoms among 
participants in the TAU condition (effect sizes; d = .25 to .60). Attending the group also 
appeared to reduce participants’ perceived risk of SA and improve their outcome 
expectations and treatment self-efficacy. The cognitive screening measures suggested that 
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the overall sample was functioning within the average range at baseline and no changes 
were noted at the post-assessment. The present study was the first, to our knowledge, to 
investigate the efficacy of a group intervention for CPAP adherence among a veteran 
sample. The group intervention appeared to be well tolerated, with a lower dropout rate 
than those reported in published CPAP intervention studies, and the majority of group 
completers indicated that treatment “made things a lot better.”  Barriers discovered 
during the study highlight the necessity of transdisciplinary care that integrates mental 
health with medical clinics to provide effective services to veterans. Possible future 
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Among the 2 million military personnel who have deployed to Iraq and 
Afghanistan since 2001, commonly reported psychological and physical health 
complications include PTSD, depression, mild traumatic brain injury (mTBI), and pain 
(Hoge et al., 2008; Lang, Veazey-Morris, & Andrasik, 2014). However, prevalence of 
sleep disorders among military personnel is steadily increasing (Seelig et al., 2010). 
While some studies suggest that the increased incidence of sleep problems are symptoms 
of primary disorders such as PTSD (McLay, Klam, & Volkert, 2010), research suggests 
that up to 70% of service members may continue to experience disturbances in their sleep 
following treatment of their primary disorders (Belleville, Guay, & Marchand, 2011; 
Zayfert & DeViva, 2004). This indicates that sleep disorders are an important aspect of 
the post-deployment health adjustment and deserve individual attention. One such sleep 
disturbance is sleep apnea (SA), which has been reported in over 50% of active duty 
service members (Mysliwiec et al., 2013). This sleep disorder has also gained recent 
national attention for the dramatic increase in diagnosed cases among veterans since 9/11 
(Philpott, 2013).  
 Rates of SA in the general population range from 2% to 7% with higher rates 
found in men than women (Punjabi, 2008; Ram, Sierawan, Kumar, & Clark, 2010). 
Among military personnel rates are considerably higher, ranging from 20% to 40% and 
soaring to 62% in VA treatment seeking samples (Brook 2010; Eliasson, Kashani, Dela 
Cruz, & Vernalis, 2012; Mysliwiec et al., 2013). Furthermore, studies suggest that up to 
75% of cases of sleep disordered breathing at large, including SA, go undiagnosed (Ram 
et al., 2010). The typically chronic nature of SA not only poses serious health threats and 
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disrupts quality of life but also places a significant financial burden on the Department of 
Veterans Affairs (VA). Spending has topped $500 million a year to treat veterans with 
the disorder (Brook, 2010); indicating a need to better understand and treat SA.    
Three types of SA exist—obstructive, central, and mixed—and each results in 
repetitive periods of cessation in breathing (apneas) or reductions in the amplitude of a 
breath (hypopneas), that occur during sleep (Panossian & Daley, 2013). Obstructive sleep 
apnea (OSA), the most common, is characterized by episodes of obstruction in the upper 
airway during sleep that can last up to 60 s. In central SA the brain fails to signal the 
muscles to breathe resulting in cessation of airflow and a reduction in respiratory effort 
(Panossian, & Daley, 2013). Mixed SA is a combination of the two. Severity of SA is 
measured with the apnea–hypopnea index (AHI), which is the mean number of apneas 
and/or hypopneas per hour of sleep (Punjabi, 2008). The American Academy of Sleep 
Medicine suggests SA be categorized as mild (AHI: 5-14), moderate (AHI: 15-30), and 
severe (AHI: 31 and above) (AASM, 2005). Regardless of the type of SA, during the 
apnea or hypopnea episode as the oxygen level in the blood drops, the individual is 
awakened by a surge of sympathetic nervous system activity that triggers the body to 
resume breathing (Collop, 2007). Some people experience 50 or more of these episodes 
per hour as measured with a polysomnography (PSG) sleep study (Collop, 2007).   
Symptoms and Health Complications 
Physical symptoms of SA include snoring, choking or gasping during sleep, 
insomnia, morning headache, and daytime sleepiness (Caples, Gami, & Somers, 2005). 
From a population-based study, of those people who had been diagnosed with OSA, the 
most common symptoms were snoring (48%), feeling unrested during the day (27%), 
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excessive daytime sleepiness at least 5 days per month (19%), and stopping breathing at 
least 3 nights per week (11%) (Ram et al., 2010). Other commonly reported problems 
associated with sleep disordered breathing included marital discord, increased irritability 
and depression, loss of sexual and social intimacy, loss of sleep by family members, and 
family members’ worrying about the patient’s health (Smith et al., 1998). If left 
untreated, chronic SA can lead to cognitive dysfunction, impaired work performance, and 
reductions in health-related quality of life (Punjabi, 2008). In regard to quality of life, 
Lopes and colleagues (2008) conducted a study of 1,384 patients diagnosed with OSA at 
a sleep clinic and found that reduction in quality of life was proportional to SA severity. 
Further, there was a significant decrease in all domains (physical functioning, role 
physical problems, bodily pain, general health perceptions, vitality, social functioning, 
emotional problems, and general mental health) for individuals with severe OSA.    
The oxygen desaturation that occurs in OSA can also cause a myriad of health 
problems. Chronic medical correlates of OSA include hypertension, stroke, 
cardiovascular disease and even death (Collop, 2007). Yaggi et al. (2005) found that 
across a 3-year study, people with SA had a 2-fold increased risk for either incident 
stokes or death and this was independent of other cardiovascular risk factors. In one 
population-based longitudinal study, cardiovascular mortality accounted for 42% of all 
deaths in persons who had severe sleep disordered breathing at baseline, nearly twice the 
rate among people without any sleep breathing problems (Young et al., 2008). Further, it 
has been well documented that untreated OSA can affect executive cognitive functioning 
including memory and vigilance (Kylstra, Aaronson, Hofman, & Schmand, 2013). One 
reason for this is that our central nervous system is sensitive to hypoxemia (lack of 
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oxygen). When oxygen is reduced in the brain, the resultant disruption of neurological 
functioning can cause significant cognitive impairments (Ganong, 1981).   
Complicating this picture of poor physical health is often co-occurring mental 
health problems among people with OSA. From a large review of primarily civilian 
samples, rates of comorbid depression ranged from 7-63% and anxiety from 11-70% 
(Saunamäki & Jehkonen, 2007). This variability in prevalence is likely due to 
discrepancies in study selection, patient characteristics, measures used to assess mood, 
and overlap between mood alteration and OSA symptoms. Rates of comorbidity among 
military populations appear to be more stable. Mysliwic and colleagues (2013) reviewed 
the records of 725 active duty military personnel who completed a diagnostic PSG in 
2010 to assess their comorbid mental health problems. The majority of the sample was 
male and combat veterans with high rates of anxiety (16.8%), depression (22.6%), PTSD 
(13.2%), and mTBI (12.8%) with 23% of the entire sample having a comorbid condition. 
Further, individuals with combined OSA and insomnia were more likely to meet criteria 
for comorbid mental health problems compared to controls having OSA only. Similarly, 
in a review of VHA data from 1998- 2001, psychiatric disorders were more prevalent 
among individuals with OSA compared to those without; the most common diagnoses 
were depression (21%) and anxiety (16%) (Sharafkhaneh, Giray, Richardson, Young, & 
Hirshkowitz, 2005).   
Treatment and Adherence 
The OSA Task Force for the American Academy of Sleep Medicine recommends 
that OSA be approached as a chronic disease requiring long-term, multidisciplinary 
management (Epstein et al., 2009). As the severity of OSA exists along a continuum, so 
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does the intensity of treatment, which may include lifestyle/behavioral changes, medical, 
and/or surgical options. The most common and most effective treatment for OSA 
involves use of a continuous positive airway pressure (CPAP) device. This consists of a 
mask worn snugly over the nose and/or mouth with a hose that is connected to a 
compressor that emits a constant rate of air flow. This air flow splints the pharyngeal 
airway space preventing the upper airway from collapsing during sleep; leading to 
improved oxygenation and decreased sleep fragmentation (Epstein et al., 2009).   
There is a general consensus across the literature that CPAP improves physical 
health. A review by Barnes et al. (2004) concluded that individuals with severe SA who 
received CPAP treatment reported a significant improvement in neuropsychological 
functioning including vigilance and executive cognitive function. In a more recent meta-
analysis, CPAP was found to be superior to positional therapy (i.e., using a pillow/wedge 
to prevent supine sleeping position) in reducing severity of SA and increasing oxygen 
saturation in patients (Ha, Hirai, & Tsoi, 2014). Among male patients with severe SA, 
CPAP treatment has also been found to significantly reduce the risk of both fatal and 
non-fatal cardiovascular events when compared to healthy controls matched for age and 
body-mass-index (Marin, Carrizo, Vicente, & Agusti, 2005).  
The literature is mixed as to the effect of CPAP treatment on mood. Saunasmaki 
and Jehkonen’s (2007) efficacy review of CPAP studies with a minimum follow-up 
period of 3 months found that depressive symptoms improved in four of seven studies 
and anxiety symptoms improved in two of four studies. The authors concluded it is likely 
that mental health problems are often secondary to OSA and adequate CPAP treatment 
may improve depressive and anxious symptoms. However, studies examining the long-
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term effectiveness of CPAP on mood are few in number. Randomized trials have found 
CPAP therapy to improve mood when compared to treatment as usual, to placebo tablet, 
and to sham CPAP; suggesting a robust benefit (Sanchez, Martinez, Miro, Bardwell, & 
Buela-Casal, 2009). Schwartz and Karatinos (2007) conducted a longitudinal study with 
50 individuals who were evaluated with PSG and treated with CPAP adequately (> 6 hr 
night, 7 nights a week). One hundred percent of participants who had an elevated 
depression score at baseline reported a subclinical level of depression at the 6-week 
follow-up and these gains were maintained throughout a one-year follow-up. What stands 
out across studies is the likely reciprocal relationship between mood and OSA symptoms 
that complicates diagnosis and treatment of each disorder (Ejaz, Khawaja, Bhatia, & 
Hurwitz, 2011). In sum, CPAP therapy has the potential to improve neuropsychological 
functioning, cardiovascular health, and mood when used appropriately.  
Despite the consequences of untreated SA, compliance with CPAP treatment is 
often low; within the first 6 months of treatment studies report dropout rates from CPAP 
therapy as high as 50% (Bartlett et al., 2013). Although, it is generally agreed that at least 
6 hours of uninterrupted sleep is optimal for normal neurobehavioral and general health 
functioning (Grandner, Patel, Gehrman, Perlis, & Pack, 2010; Weaver & Chasens, 2007), 
adherence has been arbitrarily defined as usage ≥ 4 hr night, 5 days a week (Aloia, 
Knoepke, & Lee-Chiong, 2010). In an observational follow-up study of 330 veterans 
receiving CPAP therapy, only 49% of the sample met this minimal criterion for 
adherence in the first week of therapy (Platt et al., 2009).  
The presence of mental health disorders has been found to reduce CPAP 
adherence among civilian and veteran populations. Specifically, veterans with PTSD 
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and/or a mood disorder have been found to report significantly lower percentages of 
nights and hours per night of use at both 1- and 3-month follow-ups when compared to 
veterans without any mental health diagnoses (Means, Ulmer, & Edinger, 2010). In a 
retrospective study of veterans referred to a sleep disorders clinic from 2005-2009, 
adequate CPAP adherence was found in only 41% of veterans having comorbid PTSD 
and that was significantly lower than for veterans in a control group. However, even 
among veterans without PTSD, the percentage of nights with ≥ 4 hr of use (58.3%) was 
still below the recommended threshold (El-Solh, Ayyar, Akinnusi, Relia, & Akinnusi, 
2010).   
Physical and emotional side effects as well as cognitive factors have been shown 
to influence CPAP adherence. Commonly reported physical and emotional barriers 
include mask discomfort, machine noise, dryness in the nose and throat, nighttime 
awakenings, excessive air pressure, air hunger, panic or claustrophobic reactions to the 
nasal mask, and nightmares (El-Solh et al., 2010; Engleman & Wild, 2003; Hirshkowitz, 
& Lee-Chiong, 2006). Cognitive factors, such as self-efficacy or the individual’s belief in 
his or her ability to successfully engage in a novel behavior, often influence adherence 
rates as well (Sawyer et al., 2011). For example, higher initial self-efficacy scores 
strongly predicted CPAP adherence across a 6-month follow-up (Bartlett et al., 2013). In 
order to create more effective interventions to increase CPAP adherence it is important to 
further research these factors.  
Interventions  
While it is well understood that thorough patient education is essential for 
management of any chronic disease, stand-alone educational interventions to increase 
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CPAP adherence have not been successful. Across published studies there is a wide range 
in intensity of interventions from simply providing written materials, to educational 
videos, to telephone support, to in-person groups (Chervin, Theut, Bassetti, & Aldrich, 
1997; Fletcher & Luckett, 1991; Golay et al., 2006; Meurice et al., 2007; see Wickwire, 
Lettieri, Cairns, & Callop, 2013 for a detailed review). In one study with veterans, 34 
patients attended a 2-hour group session that included a video tutorial of proper CPAP 
use. Those who attended the session increased their nightly use by approximately 1 h and 
gains were maintained across a 3-year follow up (Likar, Panciera, Erickson, & Rounds, 
1997). Despite the improvement, at baseline veterans reported an average usage of 5.2 h 
night; indicating they already had met the threshold for adequate adherence. Findings 
from this study are fairly typical of others examining effects of educational interventions, 
wherein improvements in adherence are approximately 1 hr per night, with participants 
who tend to experience mild to moderate SA. Thus, the impact of educational 
interventions on people with more severe SA remains unknown.  
A limited number of studies have explored the efficacy of psychotherapy 
interventions for improving CPAP adherence. Aloia et al. (2001) randomized a small 
sample of 12 older adults newly diagnosed with SA to two 45-min sessions of either a 
Motivational Enhancement Therapy intervention or control. The intervention followed 
the principles of MI to address ambivalence over behavior change in a non-
confrontational manner; and included education on the correlates of SA to affect their 
decisional balance, a discussion of the pros and cons of CPAP, and problem solving for 
any discomfort. The control condition involved a general discussion of sleep architecture. 
Significant differences were found at the 12-week follow-up with participants in the 
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intervention group reporting greater CPAP use than those in the control (7.8 hr night 
versus 4.6 hr night (p < .04) with a large effect size (d = 1.27). Aloia et al. (2007) 
expanded their methodology with a three group RTC (n = 160): 1) Motivational 
Enhancement Therapy intervention, two 45-min sessions; 2) education intervention, two 
45-min sessions discussing the pathophysiology of apnea and its consequences; and 3) 
standard clinical care, which provided information about the consequences of SA. Fewer 
patients in the intervention conditions discontinued CPAP. However, no differences were 
observed with regards to levels of adherence, suggesting the two 45-min sessions may not 
provide an adequate amount of treatment to solidify behavioral change and promote 
greater adherence over time (Aloia et al., 2007). These results make it difficult to identify 
the active parts of treatment and indicate a more thorough evaluation of these 
interventions is warranted. 
In another study, Richards and colleagues (2007) randomized 100 newly 
diagnosed SA patients either to treatment as usual (TAU) or TAU plus a supplemental 
intervention. The TAU consisted of a single group education session and a CPAP mask 
fitting. The supplemental intervention consisted of two 1-hr CBT group sessions with bed 
partners in attendance. The intervention was based on social cognitive theory (focusing 
on increasing perceived self-efficacy, outcome expectations, and social support) that 
included correcting distorted beliefs, discussing consequences of SA, reviewing the 
effectiveness of CPAP treatment, and a demonstration of simple relaxation strategies. 
Participants were also shown a 15-min video of other patients describing their success 
with CPAP and were given a booklet with information about sleep and SA with a list of 
unhelpful thoughts and corresponding appropriate reframes. Participants in the 
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intervention condition had higher adherence at a 4-week follow-up compared to TAU 
alone (5.4 hr vs 2.5 hr; p < .001).The authors (Bartlett et al., 2013) then altered their 
design by randomizing a larger group (n = 206) of patients to a single social cognitive 
theory-based CBT group session or an equivalent amount of time devoted to social 
interaction. All patients additionally received the TAU education session. CPAP 
adherence did not differ between participants in the group intervention and the social 
interaction condition (Bartlett et al., 2013). The authors concluded that behavioral 
interventions likely need to be more intensive, take into account timing of educational 
information, and include other factors, such as self-efficacy.   
In a recent Australian study of adults newly diagnosed with OSA, participants 
were randomized to either a three-session individual MI intervention or control (45-min 
individual educational session). The MI intervention was informed by the Motivational 
Enhancement Therapy Manual developed by Miller and colleagues (Miller, Zweben, 
DiClemente, & Rychtarik, 1995), with modifications to increase the relevance to the 
OSA population (as described in Aloia, Arnedt, Riggs, Hecht, & Borrelli, 2004). Across a 
1-month, 2-month, and 3-month follow-up, individuals in the MI condition reported 
greater CPAP adherence, with an almost 50% better adherence rate at the 3-month time 
point (4.63 hr vs. 3.16 hr; p < .001). Furthermore, these clinically significant gains were 
maintained at 12 months (Olsen, Smith, Oei, & Douglas, 2011). 
To our knowledge, all prior psychotherapy intervention studies have been 
conducted with civilian samples and have consisted of one to three sessions of group or 
individual treatment. Despite the variations in content of the interventions, mean CPAP 
adherence among intervention groups at follow-up have ranged from only 3.5 hr to 5.4 hr 
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per night. Although some studies have reached the adequate care benchmark (> 70%), 
research suggests there is a direct dose-response relationship between CPAP use and 
improvements; the greater the frequency and duration of use, the better the outcome 
(Weaver et al., 2007). Hence, there is a strong need to find more effective interventions 
for individuals diagnosed with SA, particularly among veterans.  
Aim of Current Study  
The present study was designed to compare the effectiveness of treatment as usual 
(TAU) to TAU plus a CBT group intervention (created by a psychologist at the Southern 
Arizona VA, Haynes, 2013) for increasing CPAP adherence among veterans with SA in a 
randomized controlled trial (RCT). This 6-week group integrates cognitive and 
behavioral skills to promote increased use of CPAP among veterans. From preliminary 
prospective program evaluation information, 7 out of 10 veterans reported an increase in 
either number of nights CPAP was used or number of hours CPAP was used (P. Haynes, 
personal communication, November 11, 2014). The main hypothesis in the present study 
is that veterans who attend the group intervention will increase their CPAP adherence 
compared to those in the TAU condition. Secondary hypotheses are that 1) CPAP use 
will improve mood, including depression and anxiety symptoms, 2) CPAP use will 
improve cognitive function, and 3) self-efficacy will predict CPAP use.  Although this 
intervention is more time-intensive than treatments in published studies, six weeks is a 
standard length of time for psychotherapy groups within the VA system, and we 





Participants   
Participants were veterans at the Memphis Veterans Affairs Medical Center 
(VAMC) who were referred for a polysomnography (PSG) study in the Sleep Medicine 
clinic. Recruitment occurred face-to-face in the Sleep Medicine clinic when veterans 
arrived in the evenings for their PSG study
1
. Recruitment took place between September, 
2014 and February, 2015, with follow-up completed in May 2015. At the time of 
recruitment, veterans were asked to participate in a research study that may improve their 
ability to use CPAP. They were informed they would be randomly chosen to either attend 
a 6-week group or simply attend their regular medical care and if they were in the later 
condition they would be invited to attend the group at the conclusion of the study. 
Veterans were informed they would be asked to complete a number of questionnaires and 
a cognitive screening at the time of enrollment and approximately 3 months later. The 
only inclusion criterion was diagnosis of SA. Of the 113 veterans recruited, 65 refused to 
participate and 48 were enrolled (13 of which were subsequently found to be ineligible 
based on the exclusion criteria). All participants gave informed consent. Eligible 
participants were randomly assigned to either treatment as usual (TAU; n = 10) or to 
                                                 
1
 Due to higher than anticipated rates of veterans who enrolled and were subsequently 
found to be ineligible (i.e., no diagnosis of SA), procedures were altered in December, 2014 to 
allow for veterans with diagnosed SA to be recruited from their in-service appointment in the 
Sleep Medicine clinic after their PSG study to assure their eligibility prior to being recruited. At 
this appointment a staff member informed veterans that they were eligible for a research study 
that may help them adjust to using their CPAP. Veterans had the option to provide their contact 
information if they were interested, those who did so were contacted via telephone by a member 
of the research team to re-assess their interest and answer any initial questions (n = 37). Those 
veterans who remained interested were scheduled for an appointment to meet with the researcher 
and complete the informed consent and pre-assessment measures (n =13).  
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TAU plus the intervention CPAP group (n = 25)
2
. Figure 1 describes the flow of 
participants through the study.   
The eligible sample (n = 35) consisted of 34 men and 1 woman. The mean age of 
the sample was 52.8 years (SD = 9.4). The majority of the sample was African American 
(62.9%), served in the Army (45.7%), and was unemployed (48.6%). The mean service 
connection (SC) was 37.1% (SD = 35.4). Mental health diagnoses were unreliable in the 
chart and therefore were not taken into account. The sample included participants with all 
levels of SA severity (mild to severe) with an average AHI of 34.1 (SD = 29.8) and 
average BMI of 33.7 (SD = 4.1). Twenty-two participants were newly diagnosed with 
SA, the remaining had prior diagnoses with varying levels of adherence to CPAP. 
Demographic characteristics of the sample are reported in Table 1.  
Randomization    
The principal investigator randomized participants using a sequence generated 
with a blocking factor of 2. On evenings, when multiple veterans were enrolled they were 
randomized in the order they gave verbal agreement to participate. Participants were 
informed of their allocation after they completed the baseline measures. Researchers 
completing the post-assessments were not blinded to the condition. Upon completion of 




                                                 
2
 Due to lower than anticipated eligible enrollment, procedures were altered in February, 
2015 that allowed all newly enrolled participants to be allocated to the intervention condition (n = 
8) and invited participants who were previously randomized to the TAU condition to participate 














Demographic Characteristics of Sample   
 Overall (n = 35) Group (n = 25) TAU (n = 10) 
Variable    
Age, y 52.8 (9.4) 53.9 (7.9) 49.9 (12.5) 
Males, % (n) 97.1 (34) 96 (24) 100 (10) 
Race, % AA (n) 62.9 (22) 76 (19) 30 (3) 
Employment    
Full-time, % (n) 22.9 (8) 20 (5) 30 (3) 
Part-time, % (n) 17.1 (6) 12 (3) 30 (3) 
Unemployed, % (n) 48.6 (17) 56 (14) 30 (3) 
Branch     
Army, % (n) 457 (16) 44 (11) 50 (5) 
Navy, % (n) 28.6 (10) 28 (7) 30 (3) 
Guard, % (n) 8.6 (3) 4 (1) 20 (2) 
Air Force, % (n) 2.9 (1) 12 (3) - 
Marine, %( n) 2.9 (1) 4 (1) - 
SC, %  37.1 (35.4) 36.4 (36.7) 39.0 (33.8) 
BMI, kg/m
2
 33.7 (4.1) 34.2 (4.2) 32.7 (3.8) 
AHI, events/h 34.1 (29.8) 29.9 (24.8) 44.1 (38.9) 
Data are Mean (standard deviation), except for sex, race, employment, and branch, 
quoted as percentages with absolute numbers in parentheses. AA, African American; SC, 
service connection; BMI, body mass index; AHI, apnea-hypopnea index; TAU, treatment 





Treatment as Usual.  All participants attended TAU, which consisted of an in-
service appointment following their PSG study (to review their diagnosis, provide CPAP 
machine, and give instructions for use) and follow-up appointments in the Sleep 
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Medicine clinic at one month and then every three to six months to review the SmartCard 
adherence data from their CPAP machine
3
. Additionally, participants were encouraged to 
contact the Sleep Medicine clinic if they had any equipment problems. Participants in the 
TAU condition were scheduled for an appointment with a member of the research study 
approximately 3 months following their PSG study to complete the post-assessment 
measures
4
. Once participants completed the post-assessment they were invited to 
participate in the intervention group.   
Intervention. The CBT group intervention (Haynes, 2013) integrates 
psychoeducation with cognitive and behavioral skills to promote greater adherence to the 
CPAP treatment. Participants attended six weekly, 50-min sessions with a 1-month 
follow-up session
5
. Participants were provided a treatment manual at the start of first 
session that was theirs to keep. Session 1 begins with introductions and learning about the 
participants’ experience with SA and then provides education on the causes and 
consequences of SA and how CPAP treats the condition. Group members then discuss 
pros and cons of CPAP use, practice relaxation (different each session: diaphragmatic 
breathing, relaxing imagery, progressive muscle relaxation, passive muscle relaxation, 
autogenics), and are assigned homework. The subsequent sessions begin with a review of 
                                                 
3
 After the start of the research study there were procedural changes in the Sleep 
Medicine clinic and some veterans were given a CPAP machine with an internal modem that 
allowed their adherence data to be remotely accessed by a Sleep Medicine technician. For these 
participants, their Sleep Medicine follow-up appointments were conducted via telephone.   
 
4
 Due to the financial hardship of traveling to the Memphis VA, veterans were given the 
option of completing their post-assessment questionnaires via USPS and their cognitive screening 
was omitted (n = 2).  
 
5
 The initial purpose of the follow-up session was to ensure that the follow-up duration 
was equivalent across conditions. Due to inconsistent scheduling by the Sleep Medicine clinic, 
this was only implemented for the first group cohort (n = 2). All subsequent participants in the 
intervention condition completed the post-assessment at the end of their sixth group session (n 
=13).   
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previous material, discussion of adherence obstacles and solutions, new content is 
presented (see below), and participants end with relaxation and discussion of homework. 
Topics covered in the group include avoidance, desensitization to CPAP mask and 
machine, reinforcement for goal behavior, cognitive distortions related to CPAP use and 
cognitive restructuring, sleep hygiene, and relapse prevention.   
CPAP Titration and Apparatus  
Participants underwent an in-laboratory PSG study to evaluate SA based on their 
AHI index. Any participant who had an AHI > 30 during the first four hours of the PSG 
was awakened and asked to put on a CPAP machine for the remainder of the PSG study. 
The Sleep Medicine technician then conducted a manual titration of the CPAP pressure to 
treat the apnea with a target AHI < 5 per hr of sleep. At the end of the PSG study, those 
participants who were started on CPAP attended their in-service appointment and were 
provided with a CPAP to take home. All other participants returned to the Sleep 
Medicine clinic for their in-service appointment at a later date. All participants were 
provided with a REMStar Pro® CPAP (Respironics Inc., Murrysville, PA) device with a 
data-storage SmartCard™ that allows usage data to be directly downloaded from the 
machine or via a memory key. The data-storage card records run time while the mask is 
on the person’s face. A Sleep Medicine technician downloaded the data obtained from the 
data-storage cards and entered a note in the participant’s medical chart to indicate 





                                                 
6
 Due to unforeseen protocol changes in the Sleep Medicine clinic, CPAP adherence data is 
currently invalid. Thus, we chose not to use this data as an outcome measure in the present study. 
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Measures   
All measures were administered at baseline and approximately 3-months 
following the participants’ PSG study (with exception of the STTS-R; which was only 
given at the follow-up). Demographic information was collected from a review of 
participants’ chart in the CPRS system and included age, sex, body mass index, ethnicity, 
employment status, military branch, and service connection. 
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). The PCL-5 
(Weathers et al., 2013) is a 20-item self-report measure designed to assess the 20 DSM-5 
symptoms of PTSD using a 5-point Likert scale (0 = Not at All, 4 = Extremely). Veterans 
are asked to rate the extent to which they have been bothered by a problem in the past 
month (i.e., Trouble remembering important parts of a stressful experience from the 
past). Scores range from 0 to 80, with a cut-off score of 38 suggesting clinically 
significant PTSD (Weathers et al., 2013). See Appendix A. 
Beck Anxiety Inventory (BAI). The BAI (Beck, Epstein, Brown, & Steer, 1988) is 
a 21-item self-report measure to assess symptoms of anxiety. Using a 4-point Likert-type 
scale ranging from 0 to 3, based on severity of each item, individuals are asked to pick 
the statement that best describes how they have been feeling over the past week. Scores 
range from 0 to 63, with cutoffs indicating that 0-7 reflects minimal anxiety, 8-15 mild 
anxiety, 16-25 moderate anxiety, and 26-63 severe anxiety. This inventory demonstrates 
excellent internal consistency (α = .92) and acceptable test-retest reliability over 1 week 
(r(81) = .75) (Beck et al., 1988). See Appendix B. 
Beck Depression Inventory-II (BDI-II). The BDI-II (Beck, Steer, & Brown, 1996) 
is a 21-item self-report measure to assess depression severity in adolescents and adults. 
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Using a 4-point Likert-type scale ranging from 0 to 3, based on severity of each item, 
individuals are asked to pick the statement that best describes how they have been feeling 
over the past two weeks. Scores range from 0 to 63, with cutoffs indicating that 0-13 
indicates minimal depression, 14-19 mild depression, 20-28 moderate depression, and 29-
63 severe depression (Beck et al., 1996). This inventory demonstrates excellent internal 
consistency (α = .91; Beck et al., 1996).  See Appendix C.  
Pittsburgh Sleep Quality Index (PSQI). The PSQI (Buysse et al., 1989) measures 
participants’ reported sleep quality over the past month. The PSQI is comprised of 19 
items measuring the following seven components: (a) subjective sleep quality, (b) sleep 
latency, (c) sleep duration, (d) habitual sleep efficiency, (e) sleep disturbances, (f) use of 
sleep medications, and (g) daytime dysfunction. A PSQI score of five or greater, based on 
the total scale score, is recommended as the cutoff for detecting sleep impairment in a 
range of populations (Buysse, Reynolds, Monk, Berman, & Kupfer., 1989). This index 
demonstrates good internal consistency (α = .83; Buysse et al., 1989). See Appendix D. 
Epworth Sleepiness Scale (ESS). The ESS (Johns, 1991) is an 8-item, self-
administered questionnaire that measures subjective daytime sleepiness by assessing the 
self-reported frequency of falling asleep in various settings. It is rated on a 4-point scale 
(0 = would never doze, 3 = high chance of dozing), the total ESS score is the sum of 8 
item-scores and can range between 0 and 24. Values >10 are considered to indicate 
significant sleepiness (Buysse et al., 2008). Internal consistency for this scale is good 
among sleep apnea patients (α = 0.88; Johns, 1992).  See Appendix E.  
Brief Pain Inventory-Short Form (BPI). The BPI (Cleeland & Ryan, 1994) 
assesses both pain severity and pain interference in the last 24 hr (both on a scale of 0 = 
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no pain /interference to 10 = pain as bad as bad as you can imagine/completely 
interferes). The pain severity subscale score is the mean of the 4 severity questions (Pain 
at its worst, least, average, and now). The pain interference subscale score is the mean of 
the 7 interference questions (How pain has interfered with your: general activity, 
walking, work, mood, enjoyment of life, relations with others, and sleep). The BPI 
demonstrates good internal consistency ranging from 0.80 to 0.87 for the four pain 
severity items and from 0.89 to 0.92 for the seven interference items (Cleeland & Ryan, 
1994). See Appendix F.  
Perceived Self-Efficacy Measure for Sleep Apnea (SEMSA). The SEMSA 
(Weaver et al., 2003) measures cognitive factors that may influence subsequent CPAP 
use, including perception of OSA risk, treatment outcome expectancies, and perceived 
treatment self-efficacy. Risk perception is defined as the individual’s perception of health 
risks associated with OSA. Treatment outcome expectancies include the individual’s 
expectations of certain changes or improvements with CPAP treatment. Treatment self-
efficacy is defined as the individual’s belief in their own ability to use CPAP, even when 
faced with difficulties (i.e., mask discomfort, noise of device, spouse disturbed by 
CPAP). The SEMSA is a 26-item Likert-type scale with three subscales (Perception of 
Risk, Outcome Expectancies, and Treatment Self Efficacy). This measure demonstrates 
excellent internal consistency (a = 0.92; Weaver et al., 2003). See Appendix G.  
Satisfaction with Therapy and Therapist Scale-Revised (STTS-R). The STTS-R 
(Oei & Green, 2008) is a 12-item questionnaire with items rated on a 5-point Likert scale 
(1 = strongly disagree to 5 = strongly agree) with an additional item that provides a 
measure of global improvement (How much did this treatment help with the specific 
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problem that led you to therapy) rated from 1 = made things a lot better to 5 = made 
things a lot worse. The STTS-R has two subscales, Satisfaction with Therapy and 
Satisfaction with Therapist, with higher scores indicating a greater level of patient 
satisfaction. The scale has excellent internal consistency (a = .90) and correlates well 
with measures of participation in therapy, progress in therapy, and coping ability (Oei & 
Green, 2008).  See Appendix H.  
Trail Making Test (TMT). The TMT is a subtest of the Delis-Kaplan Executive 
Functioning System (D-KEFS; Delis, Kaplan, & Kramer, 2001) that has four baseline 
conditions (Visual Scanning (1), Number sequencing (2), Letter Sequencing (3), Motor 
Speed (5)) that provide normative data and quantify several key components for the one 
higher-level executive-function condition (Number-Letter Sequencing (4)). Time is the 
primary performance measure with a limit of 150 seconds for the baseline conditions and 
240 seconds for the higher-level condition. Participants’ raw score is their completion 
time, up to the time limit, which is then converted to an age-normed scaled score with M 
= 10 and SD = 3. Additionally, scores on the Number sequencing and Letter Sequencing 
conditions are combined to create a composite sequencing score (M = 10 and SD = 3). 
The internal consistency for the composite sequencing score is good (range a = .59 to a = 
.80 based on age group) (Delis et al., 2001).  
Mental Control (MC). The MC is a subscale of the Wechsler Memory Scale III 
(WMS; Wechsler, 1997) that assesses memory retrieval and speed of mentally processing 
information. The MC subtest is composed of eight timed tasks, such as reciting the 
alphabet and to perform novel multitasking skills, such as alternately saying the days of 
the week and counting by sixes. Subtest scores reflect accuracy and speed. The subscale 
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total score has a range of 0 – 40 and raw scores are converted to an age-corrected scale 
score (M = 10, SD = 3). This subscale demonstrates good internal consistency (r = .87) in 
a generalizability study (Wechsler, 1997).  
Digit Span (DS). The DS is a subtest of the Wechsler Memory Scale III (WMS; 
Wechsler, 1997) that includes digit span forward and digit span backward. Digit span 
forward is a measure of focused attention and digit span backward is a measure of 
working memory. Scores on both forward and backward are combined for the total raw 
score (range 0 to 30), which is converted to an age-corrected scale score (M = 10, SD = 
3). This subscale demonstrates good internal consistency (r = .86) in a generalizability 
study (Wechsler, 1997).   
Statistical Analysis 
Independent-samples, t-tests, and chi-squared tests were used to check for any 
significant differences in demographics and pre-assessment measures between 
participants who completed the study (“completers”) and those who dropped out (“drop 
outs”) as well as between participants randomized to the group compared to TAU 
condition. Descriptive statistics were used to examine the baseline severity of symptoms. 
Due to the invalid CPAP adherence data, the statistical analyses reflect what was possible 
given the available data. Adjusted hypotheses were that 1) participants in the CPAP 
group would show improved scores on the post-assessment compared to those in the 
TAU condition and 2) these improvements would be a significant change from their pre-
assessment. One-way analysis of covariance (ANCOVA) tests were conducted to 
examine the differences between the TAU and CPAP group participants’ post-assessment 
scores controlling for their initial differences using pre-assessment results. Due to the low 
23 
 
n-values (i.e., groups containing fewer than 15 participants), which may misrepresent the 
statistical significance of the scores due to a low degree of freedom value (Green & 
Salkin, 2003), we then conducted follow-up paired sample t-tests within conditions to test 
for any significant changes from pre- to post-assessment scores. Cohen’s d effect sizes 
were also calculated using Morris and DeShon’s (2002) recommendations for within-
subject comparisons. This formula (http://www.cognitiveflexibility.org/effectsize/)  
corrects for dependence among means by including the correlation between pre and 








Descriptive Statistics  
In testing for group differences, completers and drop outs differed significantly on 
perceived risk of SA (t(30) = 2.2, p = .04; completers M = 23.0, SD = 4.8, drop outs M = 
18.9, SD = 5.4) and treatment self-efficacy (t(29) = 2.3, p = .03; completers M = 28.2, SD 
= 5.4, drop outs M = 23.7, SD = 4.6) such that participants with greater perceived risk and 
higher self-efficacy were more likely to be completers.  
Analyses were then conducted to determine if there were significant differences 
between participants randomized to the group (n = 25) and TAU (n = 10) conditions on 
demographics or pre-assessment measures. Participants differed significantly on race (X
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(1, N = 35) = 6.5, p = .01) such that African American participants were more likely to be 
in the group condition. There were also significant differences on sleep impairment 
(PSQI t(31) = -2.1, p = .04) and treatment self-efficacy (t(29) = 3.8, p = .001), such that 
participants with greater sleep impairment and lower treatment self-efficacy were more 
likely to be in the group condition. Demographic characteristics of the sample are shown 
in Table 1. Pre- and post-assessment means for TAU and CPAP group conditions are 









Pre- and Post-assessment Means and Standard Deviations  












PCL-5 45.4 (20.5) 40.7 (22.1) 33.6 (18.6) 38.3 (13.0) 
BDI-II 25.4 (10.9) 23.0 (12.3) 20.9 (10.6) 18.7 (8.5) 
BAI 30.2 (17.2) 28.6 (13.9) 20.0 (13.8) 24.9 (10.3) 
BPI-Severity 5.4 (2.5) 5.3 (2.9) 4.0 (3.0) 4.3 (2.3) 




PSQI 14.6 (4.1) 13.4 (5.1) 10.0 (5.3) 8.3 (3.8) 




SEMSA-A 23.6 (4.9) 22.5 (5.9) 21.7 (4.8) 20.3 (3.7) 
SEMSA-B 28.6 (7.0) 29.1 (6.3) 31.3 (5.8) 29.7 (3.3) 
SEMSA-C 25.8 (4.5) 26.7 (5.3) 33.1 (3.4) 31.4 (4.3) 
Cognitive 
b
   
DS 8.9 (2.5) 9.2 (2.8) 8.6 (2.0) 9.2 (2.8) 
MC 9.3 (2.9) 9.8 (2.5) 9.9 (2.5) 8.8 (2.8) 
TMT1 9.6 (2.3) 10.4 (3.0) 8.6 (3.3) 8.6 (4.8) 
TMT2 10.1 (4.0) 10.0 (3.0) 10.4 (2.6) 9.4 (4.6) 
TMT3 9.4 (4.1) 11.3 (2.8) 9.3 (1.9) 9.6 (3.0) 
TMT4 8.4 (4.4) 8.8 (4.5) 8.6 (3.7) 10.2 (3.1) 
TMT5 10.4 (2.6) 10.1 (2.6) 8.4 (3.2) 8.6 (3.1) 
TMT-Sequencing 10.2 (4.2) 11.4 (3.0) 10.3 (2.4) 10.0 (4.3) 
 n = 5 for post-assessment cognitive measures.  
a
 lower scores better; 
b 
higher scores better.  
PCL-5, Posttraumatic Stress Disorder Checklist- DSM-5; BDI-II, Beck Depression 
Inventory-II; BAI, Beck Anxiety Inventory; BPI, Brief Pain Inventory; PSQ, Pittsburg 
Sleep Quality Index; ESS, Epworth Sleepiness Scale; SEMSA, Perceived Self-Efficacy 
Measure for Sleep Apnea (A, Perceived Risk; B, Outcome Expectancies; C, Treatment 




Primary Analyses    
ANCOVA tests were conducted to evaluate whether the mean of the dependent 
variable (post-assessment scores), adjusted for differences in the covariate (pre-
assessment scores), differed between the TAU and CPAP group conditions. After 
adjusting for pre-assessment scores, there was no significant difference between the two  
groups on post-assessment scores on severity of PTSD, F (1, 18) = 1.61, p = .22, ηp
2
 = 
.08; depression, F (1, 18) = .09, p = .77, ηp
2
 = .00; anxiety, F (1, 17) = .07 p = .79, ηp
2
 = 
00; pain, F (1, 18) = .02, p = .90, ηp
2
 = .00; or pain interference, F (1, 18) = 0.14, p = .71, 
ηp
2
 = 00. Similarly, there was no significant difference between the two groups on the 
self-efficacy domains; Perceived Risk, F (1, 18) = 0.42, p = .53, ηp
2
 = .02; Outcome 
Expectancies, F (1, 18) = .01, p = .91, ηp
2
 = .00; Treatment Self-Efficacy, F (1, 18) = .36, 
p = .56, ηp
2
 = .02. Regarding the cognitive measures, there was a statistically significant 
difference between the two groups for Mental Control (F (1, 16) = 4.41, p = .05, ηp
2
 = 
.22) such that participants in the CPAP group condition significantly improved their post-
assessment Mental Control score compared to TAU.  There were no significant 
differences between the two groups for any of the other cognitive measures; Digit Span, 
F (1, 16) = .01, p = .92, ηp
2
 = .00; Trails 1, F (1, 16) = .12, p = .74, ηp
2
 = .00; Trails 2, F 
(1, 16) = .37, p = .55, ηp
2
 = .02; Trails 3, F (1, 16) = 2.43, p = .14, ηp
2
 = .13; Trails 4, F 
(1, 16) = 2.79, p = .12, ηp
2
 = .15; Trails 5, F (1, 16) = .09, p = .76, ηp
2
 = .00; Trails 
Sequencing, F (1, 16) = 1.90, p = .19, ηp
2




Paired-samples t-tests were then conducted to determine if there were significant 
pre- to post-assessment changes on the measures among participants in the TAU and 
CPAP group conditions.  
In the CPAP group sample, PTSD symptom severity reduced from pre- to post-
assessment (PCL, t(13)= 1.73, p = .11, d = 0.50); as did severity of depression (t(13)= 
1.20, p =.25, d = 0.35) and anxiety (t(12)= 0.80, p = .44, d = 0.20) symptoms. The small 
to moderate effect sizes suggest a meaningful improvement in these mental health  
symptoms. Similarly, there were non-significant reductions in post-assessment sleep 
impairments (t(13)= 0.85, p = .41, d = 0.30) and daytime sleepiness (t(13)= 0.58, p = .57, 
d = 0.15). The moderate effect size in reducing overall sleep problems suggests 
participants experienced a meaningful change in their sleep. As expected, participants’ 
outcome expectancies and treatment self-efficacy improved at post-assessment (t(13)= -
.26, p = .80, d = 0.01; t(13)= -0.90, p = .39, d = 0.26; respectively).  Surprisingly, 
perceived risk reduced at post-assessment (t(13)= 0.79, p = .44, d = 0.23). Regarding the 
cognitive measures, six out of the eight subscales showed non-significant improvement at 
the post-assessment (DS, t(13)= -0.64, p = .54, d = 0.18; MC, t(13)= -1.46, p = .17, d = 
0.40; TMT1, t(13)= -0.88, p = .35, d = 0.30; TMT3, t(13)= -2.62, p = 0.21, d = 0.66; 
TMT4, t(13)= -1.10, p = .29, d = 0.31; TMTS, t(13)= -1.87, p = 0.8, d = 0.50) with effect 
sizes suggestive of meaningful improvements. Means and standard deviations presented 
in Table 3. Effect sizes are presented in Figure 2 and Figure 3. 
 In the TAU sample, participants’ PTSD symptom severity increased at the post-
assessment (t(6)= -0.82, p = .44, d = 0.28) as did their anxiety (t(6)= -0.67, p =.53, d = 
0.30) and pain (Severity, t(6)= -0.65, p = .54, d = 0.25; Interference, t(6)= -1.56, p =.17, d 
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= 0.60) severity. Depression symptom severity reduced at the post-assessment (t(6)=v.47, 
p = .66, d = 0.16). The small to large effect sizes suggest that participants in the TAU 
condition may have deteriorated in their mental and physical health functioning after 
being diagnosed with SA. Non-significant reductions in total sleep impairment (t(6)= .74, 
p = .50, d = 0.22) and daytime sleepiness (t(6)= .78, p = .47, d = 0.33) with small effect 
sizes suggest participants’ may have made improvements to their sleep habits. 
Participants appeared to decline in their self-efficacy domains at the post-assessment  
(Perceived Risk, t(6)= .53, p = .61, d = 0.28; Outcome Expectations, t(6)= .55, p = .60, d 
= .024; Treatment Self-Efficacy, t(6)= 1.37, p = .22, d = 0.60). The changes in cognitive 
measures were similar to those in the CPAP group condition, five out of the eight 
subscales showed improvements at the post-assessment (DS, t(4)= -0.43, p = .69, d = 
0.22; TMT1, t(4)= -0.39, p = .72, d = 0.21; TMT3, t(4)= -0.59, p = .59, d = 0.40; TMT4, 
t(4)= -1.54, p =.20, d = 0.63; TMT5, t(4)= -2.14, p = .09, d = 1.01). Means and standard 
deviations presented in Table 4. Effect sizes are presented in Figure 2 and Figure 3. 
Overall, participants responded favorably to the CBT group. Among the 
completers, 64% rated their satisfaction with the therapy as “agree” or “strongly agree” 
and 93% rated their satisfaction with the therapist as “agree” or “strongly agree.” On the 
global improvement question, 67% reported that the treatment “made things a lot better.”  








Paired Samples T-Test, CPAP Group Condition (n = 14) 




PCL-5 45.38 (20.46) 40.71 (22.14) 1.73 0.50 
BDI-II 25.36 (10.92) 23.00 (12.31) 1.20 0.35 
BAI 29.00 (17.87) 27.32 (13.76) 0.80 0.20 
BPI-Severity 5.39 (2.50) 5.34 (2.90) 0.07 0.02 




PSQI 14.57 (4.09) 13.36 (5.08) 0.85 0.30 




SEMSA-A 23.64 (4.92) 22.50 (5.88) 0.79 0.23 
SEMSA-B 28.57 (7.00) 29.14 (6.30) -0.26 0.01 




DS 8.93 (2.53) 9.21 (2.78) -.064 0.18 
MC 9.29 (2.89) 9.79 (2.52) -1.46 0.40 
TMT1 9.64 (2.30) 10.36 (2.95) -0.97 0.30 
TMT2 10.07 (4.00) 10.00 (2.96) 0.86 0.02 
TMT3 9.43 (4.05) 11.29 (2.76) -2.62 0.66 
TMT4 8.36 (4.39) 8.79 (4.53) -1.10 0.31 
TMT5 10.36 (2.65) 10.07 (2.62) 0.31 0.08 
TMT-Sequencing 10.21 (4.21) 11.36 (2.95) -1.87 0.50 
Note. Effect sizes reported as Cohen’s d. 
Note. 
a
 lower scores better; 
b 
higher scores better.  
Note. PCL-5, Posttraumatic Stress Disorder Checklist- DSM-5; BDI-II, Beck Depression 
Inventory-II; BAI, Beck Anxiety Inventory; BPI, Brief Pain Inventory; PSQI, Pittsburg 
Sleep Quality Index; ESS, Epworth Sleepiness Scale; SEMSA, Perceived Self-Efficacy  
Measure for Sleep Apnea (A, Perceived Risk; B, Outcome Expectancies; C, Treatment 






Figure 2.  Effect Sizes for Pre- to Post-Assessment Change of Self-Report Measures between Groups 
Note. Effect sizes reported as Cohen’s d.  
Note. PCL-5, Posttraumatic Stress Disorder Checklist- DSM-5; BDI-II, Beck Depression Inventory-II; BAI, Beck Anxiety 
Inventory; BPI, Brief Pain Inventory; PSQI, Pittsburg Sleep Quality Index; ESS, Epworth Sleepiness Scale; SEMSA, 


































Figure 3. Effect Sizes for Pre- to Post-Assessment Change of Cognitive Measures between Groups  
Note. Effect sizes reported as Cohen’s d.  

















































Paired Samples T-Test, TAU Condition (n = 7) 
Variable Pre M (SD) Post M (SD) t d 
Mental Health (lower scores better) 
PCL-5 33.57 (18.62) 38.28 (12.98) -0.82 0.28 
BDI-II 20.86 (10.61) 18.71 (8.48) 0.47 0.16 
BAI 20.00 (13.79) 24.91 (10.31) -0.67 0.30 
BPI-Severity 3.96 (2.99) 4.32 (2.29) -0.65 0.25 
BPI-Interference 2.65 (2.97) 3.5 (2.63) -1.56 0.60 
Sleep (lower scores better) 
PSQI 10.00 (5.32) 8.42 (3.99) 0.64 0.22 
ESST 10.00 (4.12) 8.57 (4.96) 0.78 0.33 
Self-Efficacy (higher scores better) 
SEMSA-A 21.71 (4.75) 20.28 (3.68) 0.53 0.28 
SEMSA-B 31.29 (5.78) 29.71 (3.30) 0.55 0.24 
SEMSA-C 33.14 (3.39) 31.43 (4.28) 1.37 0.60 
Cognitive (higher scores better)         
DS 8.80 (2.28) 9.20 (2.77) -0.43 0.22 
MC 9.60 (2.41) 8.80 (2.77) 2.14 1.15 
TMT1 8.00 (3.81) 8.60 (4.83) -0.39 0.21 
TMT2 10.60 (2.79) 9.40 (4.56) 0.75 0.50 
TMT3 9.20 (2.04) 9.60 (2.96) -0.59 0.40 
TMT4 8.00 (4.12) 10.20 (3.11) -1.54 0.63 
TMT5 7.80 (3.42) 8.60 (3.05) -2.14 1.01 
TMT- Sequencing 10.40 (2.61) 10.00 (4.30) 0.34 0.26 
 n = 5 for post-assessment cognitive measures.  
Note. Effect sizes reported as Cohen’s d.  
Note. PCL-5, Posttraumatic Stress Disorder Checklist- DSM-5; BDI-II, Beck Depression 
Inventory-II; BAI, Beck Anxiety Inventory; BPI, Brief Pain Inventory; PSQI, Pittsburg 
Sleep Quality Index; ESS, Epworth Sleepiness Scale; SEMSA, Perceived Self-Efficacy 
Measure for Sleep Apnea (A, Perceived Risk; B, Outcome Expectancies; C, Treatment 
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Figure 6. Global Improvement  
Note. Question 13 from SST measure “How much did this treatment help with the 
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Given the conclusive literature on the negative health consequences of untreated 
SA and the ability of CPAP therapy to ameliorate those consequences, finding ways to 
promote adherence to CPAP therapy is of the utmost importance. The current study is the 
first, to our knowledge, to examine the effectiveness of a CBT group intervention for 
CPAP adherence in a veteran sample. We hypothesized that veterans attending the group 
would have increased CPAP adherence compared to those in the TAU condition and that 
CPAP use would in-turn lead to improvements in mental and physical health symptoms. 
Unfortunately, due to inconsistent and likely invalid CPAP adherence reporting in 
participant’s medical charts, we chose not to analyze this information. We were, 
however, able to test the alternatively proposed hypotheses that participants in the CPAP 
group would show improved scores on the post-assessment compared to those in the 
TAU condition and that these improvements would be a significant change from their 
pre-assessment.   
The majority of the eligible sample reported clinically significant symptoms of 
PTSD (59%), depression (62%), and anxiety (66%) with half of participants indicating 
significant distress in all three mental health domains at baseline. These rates are higher 
than previously reported both for an active duty SA sample (Mysliwic et al., 2013; 
depression = 22.6%, anxiety =16.8%, PTSD =13.2%) and a veteran SA sample 
(Sharafkhaneh et al., 2005; depression = 21.8%, anxiety =16.7%, PTSD =11.9%). 
However, both prior studies used more stringent criteria (i.e., ICD-9 codes or diagnostic 
codes), as opposed to symptom inventories, which likely accounts for some of the 
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difference in rates. As hypothesized, veterans in the group condition reported a reduction 
in their symptoms of posttraumatic stress, depression, and anxiety at the post-assessment. 
While these reductions were not statistically significant, they did evidence a small to 
moderate effect size (d = .20 to .50). This is particular encouraging given participants in 
the TAU evidenced increased symptoms of PTSD, anxiety, and pain at the post-
assessment (d = .25 to .60). The reduction in mean BDI score among the group 
participants in the present study is nearly double what has been reported in prior veteran 
and civilian samples after initiation of CPAP (Means et al., 2003; Sanchez, Buela-Casal, 
Bermudez, & Casas-Maldonado, 2001). Outcomes with anxiety are more varied in the 
literature (Saunasmaki & Jehkonen, 2007). Overall, it is likely that a reciprocal 
relationship exists between mood and SA that complicates treatment of each disorder 
(Ejaz et al., 2011). However, the effect sizes in the present study suggest that the group 
participants were able to make a meaningful change in their mental health symptoms and 
likely in their quality of life.  
In addition to the sample having an average AHI score in the severe range, thirty-
one participants (88.6%) had PSQI scores >5, indicating poor sleep quality, and twenty 
two participants (62.9%) had ESS scores >10, indicating significant daytime sleepiness. 
Participants in both conditions showed improvements in sleep quality and daytime 
sleepiness, with small effect sizes despite non-statistically significant changes. This was 
surprising, given that in prior studies the ESS was found to be sensitive to chance in non-
veteran SA patients who started CPAP (Johns, 1993). Although the standard clinical 
understanding is that by treating an individuals’ nocturnal breathing disorder, their sleep 
will be improved; there is emerging evidence suggesting that this may not be the case. In 
37 
 
a large sample of OSA patients who began using PAP adequately, the majority continued 
to report disturbed sleep 2 months and 4 months after starting therapy (Stepnowsky, 
Zamora, & Edwards, 2014).  One potential explanation is that the PSQI and ESS assess 
habitual patterns of sleep and sleepiness, which may take longer to improve once the 
sleep breathing disorder is treated and/or may require direct intervention simultaneous 
with starting CPAP therapy.  
Regarding the self-efficacy domains, more than 60% of the participants viewed 
most of the possible risks as being associated with SA including being depressed and 
having a heart attack. Approximately half the sample did not perceive that falling asleep 
while driving or having an accident as related to SA. The majority of the sample linked 
the use of CPAP to positive outcomes including feeling better and being more active. 
Similarly, the majority of the sample believed that they could overcome the obstacles to 
CPAP use presented to them, including having to pay for some of the cost themselves.  
These findings suggest that the current sample held more accurate beliefs about OSA and 
had higher treatment self-efficacy compared to the initial validation sample of 213 
patients from a civilian population (Weaver et al., 2003). In the present study, veterans 
who completed the group had a reduction in their perceived risk of SA and improvement 
in their CPAP outcome expectations and treatment self-efficacy at the post-assessment. 
Although not statistically significant, they demonstrated improvement with small effect 
sizes whereas participants in the TAU condition showed declines in their self-efficacy 
with small to moderate effect sizes. The reduction in perceived risk is counter intuitive; 
however, Olsen and colleagues (2008) reported that in a sample of newly diagnosed OSA 
patients a lower perceived risk of negative health consequences was associated with 
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greater adherence at 4-month follow-up. Few studies have investigated how interventions 
alter self-efficacy domains relating to SA. However, there is a substantial literature on 
self-efficacy with other chronic illnesses. Petrie and colleagues (2002) conducted a 
prospective, randomized study of 65 patients who experienced their first myocardial 
infarction. Half of the sample attended a 3-session intervention, designed to alter their 
perceptions about their illness, all participants attended routine care with a rehabilitation 
nurse. Patients in the intervention condition reported lower levels of belief that their heart 
condition would cause serious consequences (analogous to the perceived risk domain in 
the present study) and higher levels of belief that their heart condition could be controlled 
(i.e., self-efficacy), and lower levels of distress about their heart condition symptoms 
(Petrie, Cameron, Ellis, Buick, & Weinman, 2002). Similarly to the findings in the 
present study, the reduction in perceived risk could be explained on an individual level in 
that participants’ beliefs that their personal risk of consequence was reduced due to the 
increased use of CPAP/treatment. 
The cognitive screening measures suggest that the overall sample was functioning 
within the average range at baseline (M = 9.33 to 10.09, SD = 2.31 to 3.47). There were 
no significant changes at the post-assessment, as would be expected given their baseline 
functioning. It is widely accepted that CPAP improves cognition with frequently reported 
improvements in the domains of attention, vigilance, memory, and executive functioning 
(Aloia, Arnedt, Davis, Riggs, Byrd, 2004; Sánchez et al., 2009; Weaver & Chasens, 
2007). However, a recent meta-analysis showed only small improvements in cognitive 
functioning after CPAP, specifically in the attention domain (Kylstra et al., 2013). This 
meta-analysis implemented more stringent criteria for study inclusion and inclusion of 
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weighted study effects compared to previous reviews, which suggests the results may be 
more representative of actual functioning. Recent research suggests that although CPAP 
use has not yielded conclusive results in improving cognitive function, it has shown 
promise in delaying onset of cognitive decline in an elderly sample (Osorio et al., 2015). 
While the lack of CPAP adherence data in the present study, prevents us from drawing 
conclusions as to the relative value of CPAP for improving cognitive function, 
participants in the group condition improved in more subscales (6 out of 8) with stronger 
effect sizes at post-assessment compared to the TAU. Clearly, further studies are needed 
to determine the potential changes in cognitive function in SA patients using CPAP.    
As we anticipated, the six-week group structure appeared to be well-tolerated by 
the veteran sample. Of those participants who attended the first group session, the 
dropout rate was 16% (n = 4; moved, work obligations, unreliable transportation). 
Among completers, participants drove to the Memphis VA from up to 85 miles away. 
Overall participants responded favorably to the CBT group, 64% rated their satisfaction 
with the therapy as “agree” or better and 93% rated their satisfaction with the therapist as 
“agree” or better. On the global improvement question, 93% reported that the treatment 
“made things a lot better.” The favorable reports of satisfaction with therapy and therapist 
combined with strong effect sizes for self-efficacy scores suggest that the CBT group 
intervention helped veterans gain knowledge about the potential benefits of CPAP use 
and confidence in their abilities to adhere to the treatment.   
Study Limitations 
There were numerous limitations in this study that warrant discussion. First and 
foremost, was our inability to analyze CPAP adherence data. Our reliance on the 
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objective adherence data being collected by a different clinic (Sleep Medicine clinic) 
limited our ability to impose reliable collection of that data. Despite their best efforts, the 
Sleep Medicine clinic has a high patient volume and is under-staffed, which often 
resulted in patients not being scheduled for appointments when intended. Unfortunately, 
it was not feasible for key staff in that clinic to devote as much effort into ensuring 
patients maintained regular appointments and providing needed data as the researchers 
requested. Additionally, the CPAP adherence data recording methods varied between 
staff, with some reporting mean hours/minutes of usage and others omitting this type of 
information. The time frames over which the adherence data were reported also varied 
considerably, often rendering them uninterpretable for our purposes. For example, one 
veteran presented for follow-up one week after she completed the group intervention; 
however, her compliance was reported across the 10 months since her most recent 
follow-up appointment, making it impossible to ascertain if her adherence improved as a 
result of the CPAP group. Lastly, midway through the research study the Sleep Medicine 
clinic introduced new CPAP models that allowed for remote data access. Unfortunately, 
as common with new technology, there were many “kinks” in the system and the data 
downloaded via the remote modem was unreliable through the duration of the study.  
 Another limitation is that the recruitment took place in a clinic other than where 
the intervention occurred, which negatively impacted enrollment and likely reduced 
patient “buy-in”. Although we believe we had strong “buy-in” from the staff in the Sleep 
Medicine clinic, marketing the study to the potential participants was difficult at times. A 
protocol change, which allowed for the Sleep Medicine clinic technician to tell veterans 
about the study when they attended their in-service appointment, seemed to provide 
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confidence to the veterans that the study may be of benefit to them. The relatively high 
number of missing values for the cognitive measures at the post-assessment for TAU 
participants was a further limitation. This occurred when it would have been a financial 
hardship for veterans to travel to the VA (they all agreed to complete the questionnaires 
via the mail).   
Several limitations are a result of conducting a research study within the VA 
system. We had a very liberal inclusion criterion (i.e., diagnosis of SA) and no other 
exclusion criteria, which makes it difficult to draw conclusions as to the factors that may 
predict adherence. However, this is congruent with actual clinical practice where the goal 
is to include any individual who could potentially benefit from intervention. Additionally, 
having to conduct the study across various clinics is in-part imposed by the structure of 
hospital and care systems, which were historically organized to respond rapidly to acute 
illness with the patient’s role being largely passive (Wagner et al., 2001). As a result, care 
for chronic conditions such as hypertension, congestive heart failure, and diabetes is often 
suboptimal. The difficulty in the present study of recruitment and obtaining necessary 
outcome data to evaluate study outcomes all speak to these realities.   
A strength to the study is that it is the first attempt, to our knowledge, at 
conducting a CBT group intervention for CPAP adherence in a veteran sample. We are 
thus able to provide a description of a representative sample of veterans with SA to add to 
the literature on this chronic illness. Effect sizes suggest that participants who attended 
the CPAP group intervention had moderate reductions in severity of PTSD (d = 0.50) and 
depression (d = 0.35) symptoms and lesser reductions in anxiety (d = 0.20) symptoms. 
Additional improvements include moderate reduction in total sleep impairment (d = 
42 
 
0.30), a small increase in treatment-self efficacy (d = 0.26) and varied improvements in 
several cognitive domains (d = 0.18 to 0.66). Overall, the group was well tolerated and 
helped veterans make behavioral changes necessary for long-term adherence to CPAP 
therapy.     
Implications for Research and Practice  
We learned several valuable lessons about what to incorporate into future work. 
Recruiting and delivering high-quality chronic illness care demands planning and the 
coordinated actions of multiple caregivers (Wagner et al., 2001). As we underestimated 
the volume of recruiting effort and the rate of attrition, future studies should anticipate 
and take this into account when conducting studies with veteran samples. Including a 
veteran’s Sleep Medicine technician aided in assuring veterans that the study was 
credible. Historically low CPAP adherence rates, likely indicate a failure in these 
domains. In the present study, it was very clear that the standard information provided in 
the Sleep Medicine clinic was insufficient to promote adequate CPAP use. For example, 
numerous participants who presented to the first group session still did not understand 
what SA was or how CPAP treated the condition, even after they were provided with the 
basic facts regarding SA. As has been previously shown, education alone is often not 
sufficient to promote lasting behavioral change; however, Sleep Medicine personnel 
likely do not have the resources to provide more extensive education or behavioral 
training. Therefore, future interventions should encourage more communication and 
collaboration between disciplines and clinics. Creating a feedback loop where 
participants are asked about group topics at their Sleep Medicine appointments may help 
solidify their behavior change.  
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 As the present study provided initial descriptions of a veteran sample interested 
in an intervention for using CPAP more regularly, future studies may find this of value 
when designing investigations to account for individual differences, such as illness 
duration, cultural background, age, gender, and dispositional variables (e.g., optimism, 
self-efficacy). These variables are likely to be important to consider as possible 
moderators in the development of interventions and identifying subgroups most at-risk 
for low adherence (Nicassio, Meyerowitz, & Kerns, 2004). Additionally, the patient’s bed 
partner can play an important role in promoting adherence, with prior studies reporting 
less than half of participants would use CPAP if it disturbed their bed partner’s sleep. In a 
recent review, a dyadic perspective to CPAP use was suggested that recognized the 
nature of spousal involvement in CPAP adherence (Ye et al., 2015). Lastly, prior 
suggestions for management of chronic illness should apply to individuals with SA 
including having the confidence and skills to manage their condition, having appropriate 
treatments to assure optimal disease control, and having continuous follow-up (Wagner et 
al., 2001). Interventions, such as the CBT group in the present study are necessary to help 
veterans adequately manage their SA.    
Conclusion 
High rates of SA among military populations combined with the chronic nature of 
the disease and serious health complication indicate that SA is a major medical problem 
(Brook, 2010; Mysliwiec et al., 2013). The gold standard for treatment—CPAP 
therapy—has been demonstrated to reduce hypertension, risk of cardiovascular events 
including stroke, and even death across a variety of populations (Collop, 2007; Marin et 
al., 2005). Unfortunately, CPAP adherence is often below recommended guidelines 
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(Bartlett et al., 2013). A variety of interventions have been explored to address this lack 
of adherence with mixed results. The present study was found to be well tolerated among 
a small veteran sample and results suggest that it was beneficial in helping veterans 
increase their self-efficacy towards CPAP therapy and as a result, their CPAP use may 
have led to reductions in various mental and physical health problems. This is a 
developing field of literature that requires more investigation into barriers to CPAP use 
within in a military population and specific moderators/predictors of individuals who are 
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